Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2019 4
2020 5
2021 1
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

11 results
Results by year
Filters applied: . Clear all
Page 1
Bioactive pyrrole-based compounds with target selectivity.
Li Petri G, Spanò V, Spatola R, Holl R, Raimondi MV, Barraja P, Montalbano A. Li Petri G, et al. Eur J Med Chem. 2020 Dec 15;208:112783. doi: 10.1016/j.ejmech.2020.112783. Epub 2020 Aug 29. Eur J Med Chem. 2020. PMID: 32916311 Free PMC article. Review.
Pharmacogenetics of treatments for pancreatic cancer.
El Hassouni B, Li Petri G, Liu DSK, Cascioferro S, Parrino B, Hassan W, Diana P, Ali A, Frampton AE, Giovannetti E. El Hassouni B, et al. Among authors: li petri g. Expert Opin Drug Metab Toxicol. 2019 Jun;15(6):437-447. doi: 10.1080/17425255.2019.1620731. Epub 2019 May 24. Expert Opin Drug Metab Toxicol. 2019. PMID: 31100206 Review.
3-(6-Phenylimidazo [2,1-b][1,3,4]thiadiazol-2-yl)-1H-Indole Derivatives as New Anticancer Agents in the Treatment of Pancreatic Ductal Adenocarcinoma.
Cascioferro S, Li Petri G, Parrino B, El Hassouni B, Carbone D, Arizza V, Perricone U, Padova A, Funel N, Peters GJ, Cirrincione G, Giovannetti E, Diana P. Cascioferro S, et al. Among authors: li petri g. Molecules. 2020 Jan 14;25(2):329. doi: 10.3390/molecules25020329. Molecules. 2020. PMID: 31947550 Free PMC article.
To Combine or Not Combine: Drug Interactions and Tools for Their Analysis. Reflections from the EORTC-PAMM Course on Preclinical and Early-phase Clinical Pharmacology.
El Hassouni B, Mantini G, Li Petri G, Capula M, Boyd L, Weinstein HNW, Vallés-Marti A, Kouwenhoven MCM, Giovannetti E, Westerman BA, Peters GJ; EORTC PAMM Group. El Hassouni B, et al. Among authors: li petri g. Anticancer Res. 2019 Jul;39(7):3303-3309. doi: 10.21873/anticanres.13472. Anticancer Res. 2019. PMID: 31262850 Review.
Impact of hypoxia on chemoresistance of mesothelioma mediated by the proton-coupled folate transporter, and preclinical activity of new anti-LDH-A compounds.
Li Petri G, El Hassouni B, Sciarrillo R, Funel N, Mantini G, Zeeuw van der Laan EA, Cascioferro S, Avan A, Zucali PA, Zaffaroni N, Lagerweij T, Parrino B, Smid K, Deraco M, Granchi C, Braczko A, Smolenski RT, Matherly LH, Jansen G, Assaraf YG, Diana P, Cloos J, Peters GJ, Minutolo F, Giovannetti E. Li Petri G, et al. Br J Cancer. 2020 Aug;123(4):644-656. doi: 10.1038/s41416-020-0912-9. Epub 2020 Jun 4. Br J Cancer. 2020. PMID: 32493992 Free PMC article.
New Imidazo[2,1-b][1,3,4]Thiadiazole Derivatives Inhibit FAK Phosphorylation and Potentiate the Antiproliferative Effects of Gemcitabine Through Modulation of the Human Equilibrative Nucleoside Transporter-1 in Peritoneal Mesothelioma.
Li Petri G, Pecoraro C, Randazzo O, Zoppi S, Cascioferro SM, Parrino B, Carbone D, El Hassouni B, Cavazzoni A, Zaffaroni N, Cirrincione G, Diana P, Peters GJ, Giovannetti E. Li Petri G, et al. Anticancer Res. 2020 Sep;40(9):4913-4919. doi: 10.21873/anticanres.14494. Anticancer Res. 2020. PMID: 32878779
11 results